20 abstracts found.



Individual Patient Oesophageal Cancer Models for Tailored Treatment

Year:

Session type:

Theme: ,

John H Saunders1,2,David Onion1,Matthew Dorrington1,Pamela Collier1,Simon Parsons1,2,Anna Grabowska1

1University of Nottingham, Nottingham, UK,2Nottingham University Hospitals, Nottingham, UK


Role of CCR7 in head and neck cancer.

Year:

Session type:

Theme: ,

Haneen Basheer1,Kamyar Afarinkia1,Victoria Vinader1,Steven Shnyder1

1Institute of cancer therapeutics, University of Bradford, Bradford, UK


Vasculogenic mimicry in small-cell lung cancer

Year:

Session type:

Theme: ,

Francesca Trapani1,Robert Metcalf1,Cassandra Hodgkinson1,Rodoslaw Polanski1,Becky Bola1,Daisuke Nonaka2,Alberto Fusi2,Lynsey Priest1,Mary J. Hendrix3,Richard Seftor3,Elisabeth Seftor3,Christopher J. Morrow1,Jenny Antonello1,Ged Brady1,Crispin Miller4,Hui Sun Leong4,Dominic Rothwell1,Fiona Blackhall2,5,Kathryn Simpson1,Caroline Dive1,5

1CRUK MI, Manchester, Lancashire, UK,2The Christie NHS Foundation Trust, Manchester, Lancashire, UK,3Stanley Manne Children’s Research Institute, Robert H Lurie Comprehensive Cancer Center, Children’s Hospital of Chicago Research Center, Chicago, Illinois, USA,4The Institute of Cancer Sciences, University of Manchester, Manchester Lancashire, UK,5Cancer Research UK Manchester UCL Lung Cancer Centre of Excellence, Manchester and London, UK


Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in small cell lung cancer

Year:

Session type:

Theme: ,

Jakub Chudziak1,Deborah Burt1,Jenny Antonello1,Suzanne Dalby1,Dominic Rothwell1,Barbara Mesquita1,Daniel Morris1,Mahmood Ayub1,Sumitra Mohan1,Louise Carter1,2,Fiona Blackhall2,3,Caroline Dive1,Ged Brady1

1Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK,2Christie NHS Foundation Trust, Manchester, UK,3Institute of Cancer Sciences, University of Manchester, Manchester, UK


Polysialyltransferase inhibition modulates tumour cell growth, migration and invasion in neuroblastoma

Year:

Session type:

Theme: ,

Sara Elkashef1,Bradley Springett1,Virginie Viprey1,Rida Saeed1,Goreti Ribeiro Morais1,Mark Sutherland1,Paul Loadman1,Sue Burchill2,Laurence Patterson1,Steve Shnyder1,Robert Falconer1

1Institute of Cancer Therapeutics, University of Bradford, Bradford, UK,2University of Leeds, Leeds, UK


The identification and functional validation of microRNA-330-5p and microRNA-187 as regulators of sensitivity to chemoradiation therapy in oesophageal adenocarcinoma patients

Year:

Session type:

Theme: ,

Becky Bibby1,Christopher Cawthorne1,Cian Muldoon2,John Reynolds2,Niamh Lynam-Lennon2,Stephen Maher1,2

1University of Hull, Hull, UK,2Trinity College, Dublin, Ireland


MicroRNA-31 mediates chemoresistance in malignant pleural mesothelioma via reduced cisplatin intranuclear accumulation

Year:

Session type:

Theme: ,

Hannah Moody1,2,Michael Lind3,Stephen Maher1

1School of Biological, Biomedical and Environmental Sciences, University of Hull, Hull, UK,2Hull York Medical School, Hull, UK,3Centre for Oncology and Haemotology, Castle Hill Hospital, Hull and East Yorkshire NHS Trust, Hull, UK


DNA methylation of cell-free circulating DNA and its potential as a biomarker of high grade serous ovarian cancer

Year:

Session type:

Theme: ,

Kayleigh Davis1,Kirsty Flower1,Jane Borley1,Charlotte Wilhelm-Benartzi1,Robert Brown1

1Imperial College London, London, UK


The Warburg effect: Regulation of integrin endocytosis and function

Year:

Session type:

Theme: ,

Abbie Mead1,Marta Rucka1,Veronika Jenei1,Jeremy P. Blaydes1,Gareth J. Thomas1

1University of Southampton, Southampton, UK


The use of Latent Class Analysis to predict cancer risk based on a panel of serum biomarkers in the Swedish AMORIS study

Year:

Session type:

Theme: ,

Aida Santaolalla1,Anita Grigoriadis1,Ton Coolen1,Lars Holmberg1,Hans Garmo1,Niklas Hammar2,3,Håkan Malmström2,Göran Walldius2,Ingmar Jungner4,Mieke Van Hemelrijck1

1Kings College London, London, UK,2Karolinska Institutet, Stockholm, Sweden,3AstraZeneca Sverige, Gothenborg, Sweden,4Karolinska Institutet and CALAB Research, Stockholm, Sweden


Page 1 of 21...Last »